Psoriasis

News

Resolvyx Announces Open IND for RX-10045, the Lead Resolvin Therapeutic for Dry Eye

Published November 20, 2008, 5:30 am, Business Wire via Yahoo! Finance

BEDFORD, Mass.----Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced that the thirty day review period by the U.S. Food and Drug Administration is now complete for an investigational new drug application , with reference #77,896, supporting the use of RX-10045 for the treatment of ophthalmic diseases.

Full Story

Tags

No tags found at this time. Be the first to tag this news item, learn more.

Imagery

rx rx rx rx rx rx rx

Related Psoriasis Stories

From Various News Sources

No related news stories found.

Related Social Bookmarks

None found at this time.


News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a